Article

Wavefront-guided LASIK safe, accurate in high myopia, study reveals

LASIK using certain wavefront technology (CustomVue, Advanced Medical Optics) continues to provide accurate, safe correction of high myopia according to the results of the VISX Investigational Study Group for Higher Myopia with the U.S. Clinical Trials.

Key Points

The investigators found that there was a significant improvement in the patients' night vision, and large pupils are not a contraindication to this treatment, as reported by Robert K. Maloney, MD, MA. He is director, Maloney Vision Institute, and clinical professor of ophthalmology, University of California, Los Angeles.

In this clinical trial that included 94 patients, all eyes were targeted for emmetropia, and an 8-mm blend zone with a 6-mm optical zone was used. However, this prompted the investigator to ask whether the zone was sufficiently large to provide patients with optimal vision.

"This was an extremely challenging group of patients to satisfy," he said.

Are there aberrations?

When the investigators considered higher-order aberrations, almost no eyes had worsening of trefoil and spherical aberration greater than 0.1 D. Interestingly, 47% had an increase in coma that exceeded 0.1 D.

"This finding is striking, because one would expect the spherical aberration to increase in patients who have high myopia," Dr. Maloney said. "This tells us that the cornea really is prolate within the ablation zone, and the peripheral knee has been pushed outside of the optical zone, where it is not causing spherical aberration."

Coma increased in these eyes because no eyes were treated with iris registration, he said.

"My personal suspicion is that this represents micro decentrations of the ablation zone," Dr. Maloney said. "Wavefronts are done with photopic pupils, whereas ablations are done with small pupils. The position of the pupil shifts slightly from dilation to constriction," he said. The iris registration software in the proprietary wavefront system addresses this problem.

Iris registration software should be used when treating highly myopic patients, Dr. Maloney said, even though the ablations already are wavefront-guided.

The patients were asked before and after LASIK about the frequency with which they experienced halos around lights at night.

"Before surgery, the patients were wearing glasses, and after surgery they wore no correction. There was very little change from preoperatively to postoperatively in the frequency of halos," Dr. Maloney reported.

The exception was that, preoperatively, 2% of patients always had halos, but postoperatively, 8% reported that they always had halos.

"There was a small increase in the perception of halos in this population," he said. Patients should be warned about this possibility, he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.